Literature DB >> 6097201

Toxins in hepatic encephalopathy: the role of the synergistic effect of ammonia, mercaptans and short chain fatty acids.

M Baraldi, G Pinelli, P Ricci, M L Zeneroli.   

Abstract

Evidence has been recently produced that neurological changes which characterize hepatic encephalopathy due to fulminant hepatic failure in rats are linked with a pathology of GABA receptors. In the search for the peripheral toxins responsible for the CNS impairment present in hepatic encephalopathy it has been shown that the administration of ammonia and mercaptans and octanoic acid in normal rats reproduced behavioural and electrophysiological changes similar to those seen in galactosamine induced encephalopathy. The present report shows that a subacute administration of the above toxins induced a marked alteration of the GABA receptor complex which may account for the CNS derangement of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097201     DOI: 10.1007/978-3-642-69132-4_12

Source DB:  PubMed          Journal:  Arch Toxicol Suppl        ISSN: 0171-9750


  6 in total

Review 1.  Role of astrocytes in brain function and disease.

Authors:  Marta Sidoryk-Wegrzynowicz; Michal Wegrzynowicz; Eunsook Lee; Aaron B Bowman; Michael Aschner
Journal:  Toxicol Pathol       Date:  2010-11-12       Impact factor: 1.902

Review 2.  Pathogenesis of hepatic encephalopathy.

Authors:  L Zieve
Journal:  Metab Brain Dis       Date:  1987-09       Impact factor: 3.584

Review 3.  Supersensitivity of GABA-A receptors in hepatic encephalopathy.

Authors:  M Baraldi
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

Review 4.  Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy.

Authors:  M Baraldi; R Avallone; L Corsi; I Venturini; C Baraldi; M L Zeneroli
Journal:  Metab Brain Dis       Date:  2008-12-11       Impact factor: 3.584

5.  Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy.

Authors:  R Avallone; M L Zeneroli; I Venturini; L Corsi; P Schreier; M Kleinschnitz; C Ferrarese; F Farina; C Baraldi; N Pecora; M Frigo; M Baraldi
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

6.  A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.

Authors:  L Zieve; P Ferenci; D Rzepczynski; J Ebner; C Zimmermann
Journal:  Metab Brain Dis       Date:  1987-09       Impact factor: 3.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.